Synthesis, DNA binding and antitumor evaluation of styelsamine and cystodytin analogues

Marine Drugs

Volumn 11, Issue 2, 2013, Pages 274-299

  Fong, Hugo K H ^a   Copp, Brent R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cystodytin; DNA binding; Marine natural products; Pyridoacridine; Styelsamine

Indexed keywords

3 PHENYLPROPANAMIDE; ALKALOID; ANTINEOPLASTIC AGENT; CYSTODYTIN A; CYSTODYTIN B; CYSTODYTIN C; CYSTODYTIN D; CYSTODYTIN DERIVATIVE; CYSTODYTIN E; CYSTODYTIN F; CYSTODYTIN G; CYSTODYTIN H; CYSTODYTIN I; CYSTODYTIN IMINOQUINONE; CYSTODYTIN J; CYSTODYTIN K; NATURAL PRODUCT; STYELSAMINE A; STYELSAMINE B; STYELSAMINE C; STYELSAMINE D; STYELSAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER CELL; CELL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DNA BINDING; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CANCER; LUNG NON SMALL CELL CANCER; MELANOMA;

EID: 84875767314     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md11020274     Document Type: Article

References (27)

1. Molinski, T.F. Marine pyridoacridine alkaloids: Structure, synthesis, and biological chemistry. Chem. Rev. 1993, 93, 1825-1838.
2. Kobayashi, J.; Cheng, J.-F.; Wälchli, M.R.; Nakamura, H.; Hirata, Y.; Sasaki, T.; Ohizumi, Y. Cystodytins A, B, and C, novel tetracyclic aromatic alkaloids with potent antineoplastic activity from the Okinawan tunicate Cystodytes dellechiajei. J. Org. Chem. 1988, 53, 1800-1804.
3. Kobayashi, J.; Tsuda, M.; Tanabe, A.; Ishibashi, M.; Cheng, J.-F.; Yamamura, S.; Sasaki, T. Cystodytins D-I, new cytotoxic tetracyclic aromatic alkaloids from the Okinawan marine tunicate Cystodytes dellechiajei. J. Nat. Prod. 1991, 54, 1634-1638.
4. McDonald, L.A.; Eldredge, G.S.; Barrows, L.R.; Ireland, C.M. Inhibition of topoisomerase II catalytic activity by pyridoacridine alkaloids from a Cystodytes sp. ascidian: A mechanism for the apparent intercalator-induced inhibition of topoisomerase II. J. Med. Chem. 1994, 37, 3819-3827.
5. Appleton, D.R.; Pearce, A.N.; Lambert, G.; Babcock, R.C.; Copp, B.R. Isodiplamine, cystodytin K and lissoclinidine: Novel bioactive alkaloids from the New Zealand ascidian Lissoclinum notti. Tetrahedron 2002, 58, 9779-9783.
6. Copp, B.R.; Jompa, J.; Tahir, A.; Ireland, C.M. Styelsamines A-D: New tetracyclic pyridoacridine alkaloids from the Indonesian ascidian Eusynstyela latericius. J. Org. Chem. 1998, 63, 8024-8026.
7. Skyler, D.; Heathcock, C.H. The pyridoacridine family tree: A useful scheme for designing synthesis and predicting undiscovered natural products. J. Nat. Prod. 2002, 65, 1573-1581.
8. Bry, D.; Banaigs, B.; Long, C.; Bontemps, N. New pyridoacridine alkaloids from the purple morph of the ascidian Cystodytes dellechiajei. Tetrahedron Lett. 2011, 52, 3041-3044.
9. Marshall, K.M.; Barrows, L.R. Biological activities of pyridoacridines. Nat. Prod. Rep. 2004, 21, 731-751.
10. Skyler, D.; Heathcock, C.H. A simple biomimetic synthesis of styelsamine B. Org. Lett. 2001, 3, 4323-4324.
11. Rudi, A.; Kashman, Y. Six new alkaloids from the purple Red Sea tunicate Eudistoma sp. J. Org. Chem. 1989, 54, 5331-5337.
12. Plubrukarn, A.; Davidson, B.S. Arnoamines A and B, new cytotoxic pentacyclic pyridoacridine alkaloids from the ascidian Cystodytes sp. J. Org. Chem. 1998, 63, 1657-1659.
13. Bouffier, L.; Baldeyrou, B.; Hildebrand, M.-P.; Lansiaux, A.; David-Cordonnier, M.-H.; Carrez, D.; Croisy, A.; Renaudet, O.; Dumya, P.; Demeunynck, M. Amino- and glycoconjugates of pyrido[4,3,2-kl]acridine. Synthesis, anti-tumor activity, and DNA binding. Bioorg. Med. Chem. 2006, 14, 7520-7530.
14. Bouffier, L.; Gosse, I.; Demeunynck, M.; Mailley, P. Electrochemistry and bioactivity relationship of 6-substituted-4H-pyrido[4,3,2-kl]acridin-4-one antitumor drug candidates. Bioelectrochemistry 2012, 88, 103-109.
15. LePecq, J.B.; Paoletti, C. A fluorescent complex between ethidium bromide and nucleic acids. J. Mol. Biol. 1967, 27, 87-106.
16. Jenkins, T.C. Optical absorbance and fluorescence techniques for measuring DNA-drug interaction. In Drug-DNA Interaction Protocols; Fox, K.R., Ed.; Humana Press: Totowa, NJ, USA, 1997; pp. 195-218.
17. Tetko, I.V.; Gasteiger, J.; Todeschini, R.; Mauri, A.; Livingstone, D.; Ertl, P.; Palyulin, V.A.; Radchenko, E.V.; Zefirov, N.S.; Makarenko, A.S.; Tanchuk, V.Y.; Prokopenko, V.V. Virtual computational chemistry laboratory - design and description. J. Comput. Aid. Mol. Des. 2005, 19, 453-463.
18. ALOGPS 2.1; Virtual Computational Chemistry Laboratory: Neuherberg, Germany, 2005.
19. Snell, R.H.; Woodward, R.L.; Willis, M.C. Catalytic enantioselective total synthesis of hodgkinsine B. Angew. Chem. Int. Ed. 2011, 50, 9116-9119.
20. Nakagawa, M.; Okajima, H.; Hino, T. Photosensitized oxygenation of Nb-methoxycarbonyl tryptamines. A new pathway to kynurenine derivatives. J. Am. Chem. Soc. 1977, 99, 4424-4429.
21. Weissbach, H.; Smith, T.E.; Daly, J.W.; Witkop, B.; Udenfriend, S. A rapid spectrophotometric assay of monoamine oxidase based on the rate of disappearance of kynuramine. J. Biol. Chem. 1960, 235, 1160-1163.
22. Johannes, M.; Altmann, K.-H. A ring-closing metathesis-based approach to the synthesis of (+)-tetrabenazine. Org. Lett. 2012, 14, 3752-3755.
23. Minor, D.L.; Wyrick, S.D.; Charifson, P.S.; Watts, V.J.; Nichols, D.E.; Mailman, R.B. Synthesis and molecular modeling of 1-phenyl-1,2,3,4- tetrahydroisoquinolines and related 5,6,8,9-Tetrahydro-13bH-dibenzo[a,h] quinolizines as D1 dopamine antagonists. J. Med. Chem. 1994, 37, 4317-4328.
24. Nagubandi, S.; Fodor, G. The mechanism of the Bischler-Napieralski reaction. J. Heterocycl. Chem.1980, 17, 1457-1463.
25. Burke, T.R.; Fesen, M.R.; Mazumder, A.; Wang, J.; Carothers, A.M.; Grunberger, D.; Driscoll, J.; Kohn, K.; Pommier, Y. Hydroxylated aromatic inhibitors of HIV-1 integrase. J. Med. Chem. 1995, 38, 4171-4178.
26. Dang, H.T.; Kang, G.J.; Yoo, E.S.; Hong, J.; Choi, J.S.; Kim, H.S.; Chung, H.Y.; Jung, J.H. Evaluation of endogenous fatty acid amides and their synthetic analogues as potential anti-inflammatory leads. Bioorg. Med. Chem. 2011, 19, 1520-1527.
27. Developmental Therapeutics Program NCI/NIH. Available online: http://dtp.nci.nih.gov/ (accessed on 16 November 2012).